#Genes2Me

[pathologylab]

Join us in celebrating #InternationalWomensDay 2024! This year's theme is 'Inspire Inclusion,' emphasizing the importance of empowering and including #women from all walks of life. We at #G2M honour the achievements, resilience, strength, power, intelligence, and contributions of women worldwide. Together, we can inspire inclusion, break barriers, and create a more equitable future for all. #Happy International #WomensDay!

#IWD2024 #InspireInclusion #WomenEmpowerment #womensday2024 #happywomensday #genes2me #healthcareindustry #healthcare #internationalwomensday2024 #internationalwomensmonth

[bharatlivenewsmedia]

Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit With the launch of the “RT-Direct multiplex COVID-19 RT PCR” test kit, the Mumbai-based drug firm is expanding its diagnostics offerings, it said in a regulatory filing. With the launch of the “RT-Direct multiplex COVID-19 RT PCR” test kit, the Mumbai-based drug firm is expanding its diagnostics offerings, it said in a regulatory…

[moneyhealthfinance-blog]

Genes2Me- Bringing New Healthcare Paradigm with Genomics Genes2Me, India’s first diagnostic chain to bridge clinical diagnostics with genomics has reinvigorated the preventive healthcare sector in the country.

[social-mania]

Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit

Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit

The kit is validated by the Indian Council of Medical Research (ICMR) and much more advanced than other RT PCR tests, the drug firm said Drug major Cipla on Tuesday said it has launched a COVID-19 RT PCR testing kit in the country in partnership with diagnostics firm Genes2Me. With the launch of the “RT-Direct multiplex COVID-19 RT PCR” test kit, the Mumbai-based drug firm is expanding…

[goldwingsartsinstitute]

Genes2Me launches molecular biology product range to accelerate bioscience research, Health News, ET HealthWorld

Genes2Me launches molecular biology product range to accelerate bioscience research, Health News, ET HealthWorld

New Delhi: Genomics-focused diagnostic company Genes2Me launched a molecular biology product range to accelerate and support bioscience research under the ‘Made in India’ initiative. The product range contains Fantom-DNA polymerase that can help in precise amplification of target genes in gene-expression studies. The newly launched range includes enzyme technology, cloning, next-generation…

[untitled59750]

Genes2me: Transforming genetics for billions

Genes2me: Transforming genetics for billions

Genes2me is one of the leading clinical genomics & diagnostic entity working with a vision to bring about a meaningful change in molecular, ‘at home’ genetics and personalized medicine space. The start-up is presently recognized as one of the prominent companies leading the molecular diagnostics and manufacturing of the IVD kits segment in India. “Our current focus is on the domains of mother and…

[pathologylab]

On this #WorldSickleCellDay, we are dedicated to raising awareness and providing effective #solutions with our SCA-Q Real Time #PCR Kit for Sickle Cell #Anemia.

Our advanced in vitro #nucleicacid amplification kit is designed for the precise detection of the human beta-globin GAG-GTG [Glu-Val] #mutation using polymerase chain reaction (PCR). This kit includes all necessary reagents and enzymes for the specific amplification and direct detection of the specific amplicon in fluorescence channels (FAM).

Join us in the ongoing fight against #SickleCellAnemia with our efficient SCA-Q Real Time PCR Kit. Together, we can make a significant impact!

#WorldSickleCellDay2024 #SickleCellAwareness #PCRKit #MedicalInnovation #Healthcare #Diagnostics #sicklecell #sickle #rtpcr #polymerase #reaction #kit #ivd

[genes2me]

An inherited risk for cancer happens because a person is born with a non-working gene, also known as gene mutation. And when a person is born with gene mutation, it increases their risk of developing specific types of cancers. In India, hereditary cancer sequencing panel use is increasing as more people become aware of the dangers of inheriting cancers from their parents.

[moneyhealthfinance-blog]

Genes2Me- Bringing New Healthcare Paradigm with Genomics Genes2Me, India’s first diagnostic chain to bridge clinical diagnostics with genomics has reinvigorated the preventive healthcare sector in the country.

[consumerinfoline]

Genes2Me - For the First Time in the World, Driving Innovation by Combining Genetic Testing With Full Body Checkup

Genes2Me – For the First Time in the World, Driving Innovation by Combining Genetic Testing With Full Body Checkup

DELHI, February 18, 2019/PRNewswire/ —

In the crowded preventive health segment space, there are thousands of labs offering routine full body checkups. These packages claim to provide a ‘preventive’ health picture for all individuals. However, these checkups are merely a state of one’s current parameters. In other words, a normal full body checkup report only provides information on some of the…

[pathologylab]

G2M's #ClinicalExomeSequencing (CES) panel is rigorously engineered to sequence hard-to-capture regions such as homologous regions and repetitive sequences, which often pose challenges in #sequencing and data analysis. This panel offers detailed genomic profiling of various genetic diseases, covering a wide range of target regions like the whole coding sequence, mitochondrial genes, and hotspots such as splice junctions. The #G2M CES panel is compatible with all the commonly available #NGS platforms on the market. Additionally, this panel is complemented with a powerful data analysis platform called "Cliseq Interpreter," which is cloud-based #software for handling complex NGS data #analysis and interpretation.

To know more about these #NGSPanels, contact us at social@gmail.com or call us +91 8800821778.

Visit our website for more information: https://www.genes2me.com/next-generation-sequencing-clinical-panels/Clinical-Exome-Sequencing

#clinicalexome #ces #genes2me #nextgenerationsequencing #geneticdisease #software #panel #assays

[moneyhealthfinance-blog]

Genes2Me- Bringing New Healthcare Paradigm with Genomics Genes2Me, India’s first diagnostic chain to bridge clinical diagnostics with genomics has reinvigorated the preventive healthcare sector in the country.